Melanoma surveillance in the United States: Overview of methods

Slides:

Advertisements

Similar presentations

Racial and ethnic variations in incidence and survival of cutaneous melanoma in the United States, Xiao-Cheng Wu, MD, MPH, Melody J. Eide,

Advertisements

Ex vivo high-frequency ultrasound: A novel proposal for management of surgical margins in patients with non-melanoma skin cancer Paola Pasquali, MD,

Hair pull test: Evidence-based update and revision of guidelines

Recent trends in cutaneous melanoma incidence and death rates in the United States, Ahmedin Jemal, DVM, PhD, Mona Saraiya, MD, MPH, Pragna.

Effect of antibacterials on biofilms

Optimal time to provide skin cancer and photoprotection education to pediatric solid organ transplant recipients Lily Chen, BA, Feng Gao, MD, PhD, MPH,

Melanoma in adolescents and young adults (ages years): United States,

Analysis of US dermatology physician assistant density

Racial and ethnic variations in incidence and survival of cutaneous melanoma in the United States, Xiao-Cheng Wu, MD, MPH, Melody J. Eide,

Lauren Kwa, BA, Jonathan I. Silverberg, MD, PhD, MPH

Analysis of US dermatology physician assistant density

A girl with a solitary red bulla

Yul W. Yang, MD, PhD, David J. DiCaudo, MD

Dawn M. Holman, MPH, Zahava Berkowitz, MSc, MSPH, Gery P

Daniel S. Winchester, MD, Thomas L. Hocker, MD, Randall K. Roenigk, MD

Gery P. Guy, PhD, MPH, Meg Watson, MPH, Andrew B

Image registration of sequential transparent photographs to localize and detect new versus recurrent tumors in dermatologic and Mohs micrographic surgery

Melanoma in adolescents and young adults (ages years): United States,

Racial and ethnic variations in incidence and survival of cutaneous melanoma in the United States, Xiao-Cheng Wu, MD, MPH, Melody J. Eide,

Sarah Sung, MD, Alexa B. Kimball, MD, MPH

Surveillance and assessment of occupational dermatitis using Rhode Island workers' compensation data 1998 to 2002 Irwin B. Horwitz, PhD, Brian P. McCall,

Pediatric teledermatology: Observations based on 429 consults

Melanoma survival in the United States, 1992 to 2005

Sue-Min Lai, PhD, MS, MBA, Jessica B

JAK inhibitors in dermatology: The promise of a new drug class

Time for a change? Updated guidelines using interferon gamma release assays for detection of latent tuberculosis infection in the office setting Marisa.

Effect of appearance-based education compared with health-based education on sunscreen use and knowledge: A randomized controlled trial William Tuong,

The Melanoma Epidemic Thus Far

Smoking and risk of psoriasis: A nationwide cohort study

Methotrexate treatment in patients with a history of cutaneous melanoma and the risk of a consecutive primary melanoma: A national retrospective registry-based.

Pilot study of a skin cancer education curriculum for medical students

Applying for dermatology residency is difficult and expensive

Prevalence and predictors of total-body skin examination among US adults: 2005 National Health Interview Survey Naheed A. Lakhani, MPH, Kate M. Shaw,

The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity–United States, 2000 to 2006 Donatus U. Ekwueme, MS, PhD, Gery.

Toxic epidermal necrolysis secondary to emergency contraceptive pills

Characterization of disease burden, comorbidities, and treatment use in a large, US- based cohort: Results from the Corrona Psoriasis Registry Bruce Strober,

Global burden of urticaria: Insights from the 2016 Global Burden of Disease Study Elena Maxim, BS, Chante Aksut, MD, Derrick Tsoi, BS, Robert Dellavalle,

Chauncey C. Caldwell, MD, Sami K. Saikaly, MD, Robert P

A survey-based study on nail examinations at an American Academy of Dermatology free skin cancer screening Dayoung Ko, BS, Shari R. Lipner, MD, PhD

Liisa Väkevä, Annamari Ranki Journal of Investigative Dermatology

Socioeconomic and geographic barriers to dermatology care in urban and rural US populations Toral Vaidya, MPH, Lindsey Zubritsky, MD, Ali Alikhan, MD,

Infectious rash after riding elephants

Recent trends in cutaneous melanoma incidence and death rates in the United States, Ahmedin Jemal, DVM, PhD, Mona Saraiya, MD, MPH, Pragna.

Robert Kantor, BS, Prarthana Dalal, BS, David Cella, PhD, Jonathan I

Lip edema Journal of the American Academy of Dermatology

Aaron P. Thrift, PhD Clinical Gastroenterology and Hepatology

Pooja H. Rambhia, BA, Ivan J. Stojanov, DMD, Joshua Arbesman, MD

Seasonal patterns in alopecia areata, totalis, and universalis

Medicaid acceptance among pediatric dermatologists

The failure of breast cancer screening

Recent dermatology visit is associated with thinner Breslow depth nodular melanomas Erin X. Wei, MD, Lucy Chen, MD, Fangchao Ma, PhD, Jonette Keri, MD,

Christopher T. Cassetty, MD, Andrew F. Alexis, MD, MPH, Jerome L

Modification of the nail psoriasis severity index

Tofacitinib therapy for children with severe alopecia areata

Gordon W. Jung, MD, Patricia T. Ting, MSc, MD, Thomas G

Michelle A. Pipitone, MD, Brian Adams, MD, MPH, Anita Sheth, MD, T

Quality of life: An outcomes perspective

Minimal improvements in the global burden of skin disease from 1990 to 2013 Jessica Mounessa, Taylor Braunberger, MD, Cory A. Dunnick, MD, Robert P. Dellavalle,

A new oral anticoagulant in the setting of dermatologic surgery

A simple algorithm for evaluating dermatologic disease in critically ill patients: A study based on retrospective review of medical intensive care unit.

Eyebrow transplantation: Alternative body sites as a donor source

Gaps in pain management in dermatology: A needs assessment from Canada

The epidemiology of molluscum contagiosum in children

Deficiency of sun protection advertising exists in consumer magazines across demographic groups and varies by target demographic Lauren E. Wiznia, MD,

Numerous hyperpigmented macules of the oral mucosa

Brittany G. Craiglow, MD, Brett A. King, MD, PhD

Epidemiology of Thymoma and Associated Malignancies

Randomized study of topical tacrolimus ointment as possible treatment for resistant idiopathic pruritus ani Erwin Suys, MD Journal of the American Academy.

“Boot foot” with pseudomonas colonization

Stuart M. Goldsmith, MD, Armand B. Cognetta, MD

Presentation transcript:

Melanoma surveillance in the United States: Overview of methods Meg Watson, MPH, Christopher J. Johnson, MPH, Vivien W. Chen, PhD, Cheryll C. Thomas, MSPH, Hannah K. Weir, PhD, Recinda Sherman, MPH, Myles Cockburn, PhD, Jeannette Jackson-Thompson, MSPH, PhD, Mona Saraiya, MD, MPH Journal of the American Academy of Dermatology Volume 65, Issue 5, Pages S6.e1-S6.e12 (November 2011) DOI: 10.1016/j.jaad.2011.04.037 Copyright © 2011 American Academy of Dermatology, Inc. Terms and Conditions

Fig 1 States and metropolitan areas supported by Centers for Disease Control and Prevention's National Program of Cancer Registries (NPCR) program and National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program. Journal of the American Academy of Dermatology 2011 65, S6.e1-S6.e12DOI: (10.1016/j.jaad.2011.04.037) Copyright © 2011 American Academy of Dermatology, Inc. Terms and Conditions

Fig 2 Invasive melanoma incidence rates among non-Hispanic whites, by state, 2004 to 2006. Data are from population-based cancer registries that participate in National Program of Cancer Registries and/or Surveillance, Epidemiology, and End Results Program and meet high-quality data criteria (see Table I for list of registries). These registries cover 77.6% of population for 2004 to 2006. Rates are per 100,000 population and are age-adjusted to 2000 US standard population (19 age groups; Census P25-1130). Journal of the American Academy of Dermatology 2011 65, S6.e1-S6.e12DOI: (10.1016/j.jaad.2011.04.037) Copyright © 2011 American Academy of Dermatology, Inc. Terms and Conditions

Fig 3 Age-specific incidence rates of invasive melanoma, by sex, United States, 2004 to 2006. Data are from population-based cancer registries that participate in National Program of Cancer Registries and/or Surveillance, Epidemiology, and End Results Program and meet high-quality data criteria (see Table I for list of registries). These registries cover 77.6% of population for 2004 to 2006. Rates are per 100,000 population and are age-adjusted to 2000 US standard population (19 age groups; Census P25-1130). Journal of the American Academy of Dermatology 2011 65, S6.e1-S6.e12DOI: (10.1016/j.jaad.2011.04.037) Copyright © 2011 American Academy of Dermatology, Inc. Terms and Conditions

Fig 4 Incidence rates of invasive melanoma, by site on body and sex, United States, 2004 to 2006. Data are from population-based cancer registries that participate in National Program of Cancer Registries and/or Surveillance, Epidemiology, and End Results Program and meet high-quality data criteria (see Table I for list of registries). These registries cover 77.6% of population for 2004 to 2006. Rates are per 100,000 population and are age-adjusted to 2000 US standard population (19 age groups; Census P25-1130). NOS, Not otherwise specified. Journal of the American Academy of Dermatology 2011 65, S6.e1-S6.e12DOI: (10.1016/j.jaad.2011.04.037) Copyright © 2011 American Academy of Dermatology, Inc. Terms and Conditions

Fig 5 Mean melanoma incidence rates, by stage, in 3 groups of US states, 2004 to 2006. Melanoma incidence rates for states divided into 3 tertiles on basis of their rates of early-stage melanoma. Although early-stage rates vary widely, late-stage rates are similar. Data are from population-based cancer registries that participate in National Program of Cancer Registries and/or Surveillance, Epidemiology, and End Results Program and meet high-quality data criteria (see Table I for list of registries). These registries covered 77.6% of population for 2004 to 2006. Rates are per 100,000 population and are age-adjusted to 2000 US standard population (19 age groups; Census P25-1130). Journal of the American Academy of Dermatology 2011 65, S6.e1-S6.e12DOI: (10.1016/j.jaad.2011.04.037) Copyright © 2011 American Academy of Dermatology, Inc. Terms and Conditions

Fig 6 State example: Louisiana. Data from Louisiana Tumor Registry. Rates are per 100,000 population and are age-adjusted to 2000 US standard population (19 age groups; Census P25-1130). Journal of the American Academy of Dermatology 2011 65, S6.e1-S6.e12DOI: (10.1016/j.jaad.2011.04.037) Copyright © 2011 American Academy of Dermatology, Inc. Terms and Conditions

Fig 6 State example: Louisiana. Data from Louisiana Tumor Registry. Rates are per 100,000 population and are age-adjusted to 2000 US standard population (19 age groups; Census P25-1130). Journal of the American Academy of Dermatology 2011 65, S6.e1-S6.e12DOI: (10.1016/j.jaad.2011.04.037) Copyright © 2011 American Academy of Dermatology, Inc. Terms and Conditions

Journal of the American Academy of Dermatology 2011 65, S6. e1-S6 Journal of the American Academy of Dermatology 2011 65, S6.e1-S6.e12DOI: (10.1016/j.jaad.2011.04.037) Copyright © 2011 American Academy of Dermatology, Inc. Terms and Conditions